Overview
Northwest Healthcare Q2 2025 revenue falls 16.9% to C$99 million due to asset sales
Net income for Q2 2025 reaches C$32.6 mln, reversing prior year loss
Co suspends DRIP and appoints CEO Zachary Vaughan to Board
Outlook
Company manages rent deferral with Healthscope, expecting repayment by March 2026
Result Drivers
ASSET SALES - Revenue decreased 16.9% in Q2 2025 due to non-core asset sales, partially offset by same property revenue growth
SPNOI GROWTH - Same Property Net Operating Income increased by 2.8% driven by inflationary rent adjustments and improved recoveries
DEBT REDUCTION - Proceeds from asset sales used to repay debt, reducing leverage to 48.5% from 50.0% at year-end 2024
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Net Income | C$32.62 mln | ||
Q2 FFO Per Share | C$0.11 |
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy."
Wall Street's median 12-month price target for Northwest Healthcare Properties REIT is C$5.55, about 14.2% above its August 11 closing price of C$4.76
Press Release: ID:nNFC5HMZvh
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.